Official EU label nameGlossary entry 23234

PRASTERONE

This record confirms an official common ingredient name for EU cosmetic product labelling. It does not by itself confirm that the substance is permitted, unrestricted or safe.

Global evidence snapshot

The resolved identity has matching regulatory evidence in 0 of 13 indexed market datasets: 0 country records and 0 EU Annex records. Every result and evidence gap is listed below.

0 markets with evidence

Markets checked

Markets with evidence

Evidence gaps

Resolved identifiers

Resolved substance identity

CAS:53-43-0

EC:200-175-5

Ingredient index records:

PRASTERONE

Cosmetic functions: SKIN CONDITIONING

Androst-5-en-17-one, 3-hydroxy, (3-beta)

Inventory restriction note: II/37

Open full local profile

2 matched or reported names

PRASTERONEprasterone

Regulatory evidence across markets

None of the 13 markets tracked here holds an imported rule under the name PRASTERONE.

That is a statement about this inventory, not about the law: no imported rule is not evidence that a substance is permitted. A rule may exist under a different name, under a CAS or EC number this glossary entry does not carry, or in a dataset not yet imported.

Check the markets and their sources Search every market for this name

Chemical identity and properties

PubChem 2D chemical structure for CAS 53-43-0

CAS 53-43-0PubChem CID 5881

Dehydroepiandrosterone

Dehydroepiandrosterone is an androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands. It has a role as an androgen, a mouse metabolite and a human metabolite. It is a 3beta-hydroxy-Delta(5)-steroid, a 17-oxo steroid and an androstanoid. — ChEBI

IUPAC name: (3S,8R,9S,10R,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one

Molecular formula: C19H28O2
Molecular weight: 288.4 g/mol
Exact mass: 288.208930132 Da
XLogP3: 3.2
Topological polar surface area: 37.3 Å²
Hydrogen-bond donors: 1
Hydrogen-bond acceptors: 2
Covalent units: 1
Defined stereocentres: 6

Also known as

DHEAPRASTERONEDehydroisoandrosteroneAndrostenoloneDiandron3beta-hydroxyandrost-5-en-17-one17-HormoforinIntrarosa

16 more reported names

Prasterona3-beta-Hydroxy-5-androsten-17-onePrasteronumVaginorm5,6-DehydroisoandrosteroneBiolaifEM-760NSC-9896Androst-5-en-17-one, 3-hydroxy-, (3beta)-NSC9896459AG36T1BCHEBI:28689FidelinPrasteraNatrol dheaEnzymatic therapy

Open full PubChem record PubChem annotations 3D structure image

External database identifiers

ChEBI:CHEBI:28689
ChEMBL:CHEMBL90593
EPA DTXSID:DTXSID4020379
PubMed:23105433
PubMed:23087149
PubMed:23021477
PubMed:23001207
PubMed:22991188
PubMed:22985672
PubMed:22975513
PubMed:22951290
PubMed:22936264
PubMed:22916165
PubMed:22912365
PubMed:22905785

Retrieved from NIH PubChem on 2026-09-02 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.

Additional authoritative substance research

Each link searches that source for this identity. A link is a research route, not a claim that the source holds an exact record. What each source is, and its legal weight

Cosmetic Ingredient Review safety assessments FDA Global Substance Registration System ILO/WHO International Chemical Safety Cards Japan NITE-CHRIP NIOSH Pocket Guide to Chemical Hazards OECD eChemPortal US EPA CompTox CTX APIs

Take this record further

Screen in a formula Open standalone comparison

Official source and scope

Imported from Commission Implementing Decision (EU) 2025/1175 (dataset version EU 2025/1175). The glossary supplies common ingredient names for the ingredient list required by Article 19(1)(g); it is not an approval or safety list.

Open official Decision